GR76025B - - Google Patents

Info

Publication number
GR76025B
GR76025B GR67318A GR820167318A GR76025B GR 76025 B GR76025 B GR 76025B GR 67318 A GR67318 A GR 67318A GR 820167318 A GR820167318 A GR 820167318A GR 76025 B GR76025 B GR 76025B
Authority
GR
Greece
Prior art keywords
alkyl
piperazino
hydrogen
alkylsufone
aroylimidazol
Prior art date
Application number
GR67318A
Other languages
English (en)
Inventor
Richard A Schnettler
Richard C Dage
Grisar J Martin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of GR76025B publication Critical patent/GR76025B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR67318A 1981-02-18 1982-02-15 GR76025B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23545381A 1981-02-18 1981-02-18

Publications (1)

Publication Number Publication Date
GR76025B true GR76025B (el) 1984-08-03

Family

ID=22885573

Family Applications (1)

Application Number Title Priority Date Filing Date
GR67318A GR76025B (el) 1981-02-18 1982-02-15

Country Status (18)

Country Link
EP (1) EP0058435B1 (el)
JP (1) JPS57150668A (el)
KR (1) KR860001338B1 (el)
AT (1) ATE24496T1 (el)
AU (1) AU558789B2 (el)
CA (1) CA1173047A (el)
DE (1) DE3274855D1 (el)
DK (1) DK161250C (el)
ES (1) ES8307002A1 (el)
GB (1) GB2093031B (el)
GR (1) GR76025B (el)
HK (1) HK61586A (el)
IE (1) IE52422B1 (el)
IL (1) IL65010A0 (el)
MY (1) MY8600710A (el)
NZ (1) NZ199733A (el)
PH (1) PH18106A (el)
ZA (1) ZA82969B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
ZA826501B (en) * 1982-09-06 1984-04-25 Du Pont Anti-hypertensive imidazole derivative
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
EP1737447A1 (en) * 2004-03-22 2007-01-03 Myogen, Inc. (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
CA2560528A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
NZ199733A (en) 1985-05-31
ZA82969B (en) 1983-09-28
PH18106A (en) 1985-03-21
AU8048682A (en) 1982-08-26
DK161250B (da) 1991-06-17
IE820333L (en) 1982-08-18
IL65010A0 (en) 1982-04-30
ES509636A0 (es) 1983-07-01
ATE24496T1 (de) 1987-01-15
DK161250C (da) 1991-12-09
GB2093031A (en) 1982-08-25
EP0058435B1 (en) 1986-12-30
JPH048421B2 (el) 1992-02-17
IE52422B1 (en) 1987-10-28
KR860001338B1 (ko) 1986-09-15
GB2093031B (en) 1984-10-24
ES8307002A1 (es) 1983-07-01
EP0058435A3 (en) 1984-03-21
AU558789B2 (en) 1987-02-12
KR830009045A (ko) 1983-12-17
DE3274855D1 (de) 1987-02-05
EP0058435A2 (en) 1982-08-25
CA1173047A (en) 1984-08-21
MY8600710A (en) 1986-12-31
JPS57150668A (en) 1982-09-17
HK61586A (en) 1986-08-29
DK67582A (da) 1982-08-19

Similar Documents

Publication Publication Date Title
DK1026147T3 (da) Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater
FR2512024B1 (el)
DK0491664T3 (da) Indolderivater som serotonin-antagonister
ES8603711A1 (es) Procedimiento para preparar compuestos benzimidazoles 2-piridilmetil-tio y sulfinil substituidos
GB2093031B (en) 4-aroylimidazol-2-ones
ES2001794A6 (es) Un procedimiento para la preparacion de derivados de quinolina
FI863872A (fi) Nya piperazinkarboxiamider med en fenoxialkyl- eller tiofenoxialkylsidokedja.
ES8604557A1 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES8601864A1 (es) Procedimiento para la obtencion de benzoil-ureas.
AU552310B2 (en) 4-aroylimidazolin-2-ones
ITMI911095A0 (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
MX9804482A (es) Quinolinas y quinazolinas utiles en terapias.
JPS5430166A (en) 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts
ATE99306T1 (de) Antagonisten von leukotrien d4.